145 related articles for article (PubMed ID: 29481712)
1. The impact of adjuvant chemoradiotherapy timing on survival of head and neck cancers.
Tam M; Wu SP; Gerber NK; Lee A; Schreiber D; Givi B; Hu K
Laryngoscope; 2018 Oct; 128(10):2326-2332. PubMed ID: 29481712
[TBL] [Abstract][Full Text] [Related]
2. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.
Murphy CT; Galloway TJ; Handorf EA; Egleston BL; Wang LS; Mehra R; Flieder DB; Ridge JA
J Clin Oncol; 2016 Jan; 34(2):169-78. PubMed ID: 26628469
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Chemoradiation Therapy for Cervical Cancer and Effect of Timing and Duration on Treatment Outcome.
Jhawar S; Hathout L; Elshaikh MA; Beriwal S; Small W; Mahmoud O
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1132-1141. PubMed ID: 28721897
[TBL] [Abstract][Full Text] [Related]
5. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
[TBL] [Abstract][Full Text] [Related]
6. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
7. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
Kiyota N; Tahara M; Okano S; Kawashima M; Matsuura K; Onozawa Y; Nibu K; Hayashi R; Yoshimura K; Ohtsu A
Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484
[TBL] [Abstract][Full Text] [Related]
8. Treatment delays in oral cavity squamous cell carcinoma and association with survival.
Fujiwara RJ; Judson BL; Yarbrough WG; Husain Z; Mehra S
Head Neck; 2017 Apr; 39(4):639-646. PubMed ID: 28236349
[TBL] [Abstract][Full Text] [Related]
9. The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients.
Chen MM; Roman SA; Sosa JA; Judson BL
JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):137-41. PubMed ID: 25474617
[TBL] [Abstract][Full Text] [Related]
10. The impact of timing of adjuvant therapy on survival for patients with glioblastoma: An analysis of the National Cancer Database.
Amsbaugh MJ; Yusuf M; Gaskins J; Burton E; Woo S
J Clin Neurosci; 2019 Aug; 66():92-99. PubMed ID: 31104962
[TBL] [Abstract][Full Text] [Related]
11. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
[TBL] [Abstract][Full Text] [Related]
12. Comparison cisplatin with cisplatin plus 5FU in head and neck cancer patients received postoperative chemoradiotherapy.
Chen CC; Lin JC; Chen KW
Oral Oncol; 2017 Jun; 69():11-14. PubMed ID: 28559014
[TBL] [Abstract][Full Text] [Related]
13. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
[TBL] [Abstract][Full Text] [Related]
14. The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective Study.
Stoker SD; Fles R; Herdini C; Rijntjes FJ; Tjokronagoro M; Dwidanarti SR; Sikorska K; Leemans CR; Schmidt MK; Al-Mamgani A; Wildeman MA; Haryana SM; Indrasari SR; Tan IB
PLoS One; 2016; 11(3):e0151899. PubMed ID: 27030990
[TBL] [Abstract][Full Text] [Related]
15. Survival Rates of Concurrent Chemo-Radiation versus Radiation Alone in Locally Advanced, Unresectable Head and Neck Cancers: A Retrospective Cohort Study.
Eursritanakorn S
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S91-8. PubMed ID: 27266222
[TBL] [Abstract][Full Text] [Related]
16. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
[TBL] [Abstract][Full Text] [Related]
17. Quantitative survival impact of composite treatment delays in head and neck cancer.
Ho AS; Kim S; Tighiouart M; Mita A; Scher KS; Epstein JB; Laury A; Prasad R; Ali N; Patio C; Clair JM; Zumsteg ZS
Cancer; 2018 Aug; 124(15):3154-3162. PubMed ID: 29742280
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio as a prognostic factor in head and neck cancer patients.
Chen CC; Lin JC; Chen KW
Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic value of time parameters in adjuvant radiotherapy of head and neck cancer. A retrospective analysis of 138 patients].
Dietl B; Schäfer C; Kölbl O
Strahlenther Onkol; 2005 Dec; 181(12):800-7; discussion 808-9. PubMed ID: 16362791
[TBL] [Abstract][Full Text] [Related]
20. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]